Dmitry Bagrov, UK Managing Director of DataArt, spoke earlier this month at an event hosted by the Digital Leadership Forum. The event brought together over 100 digital leaders to explore the topic, “Digital Transformation Success Stories.” In his talk,...Read More
This month I attended PegaWorld 2019, a technology conference hosted in Lаs Vegas by the digital transformation software company Pega. Highlights included talks by Alan Trefler, Pega CEO, and Jeanne Ross, director of the MIT Center for Information Systems Research (CISR). In his talk...Read More
Now is the time to consider migrating from Sabre Scribe Scripts to Sabre Red Apps Sabre announced Sabre Red 360 in February 2019 and is now actively rolling it out to their partner agencies and TMCs. Sabre Red 360 brings access to a reimagined user experience that is easy to master...Read More
Daniel Piekarz, DataArt’s Head of Healthcare and Life Sciences, gives Xtalks a sneak peek at its demo applications to be presented at the Drug Information Association (DIA) Global Annual meeting in San Diego on June 24-26, 2019.
New York, June 13, 2019 — DataArt, the global technology consultancy that designs, develops and supports unique software solutions, will return to DIA 2019 on June 23-27 in San Diego, CA to exhibit and demonstrate how technology can tackle the problems in the clinical trial space.
SBC Americas posts an interview with Russel Karp, VP of Media and Entertainment at DataArt, about the innovation his team brings to the US sports betting sector.
On May 29-30, DataArt, a global technology consultancy that designs, develops, and supports unique software solutions, exhibited and spoke at the CIO Summit in Chicago. The Generis American CIO and IT Summit centers around current trends, strategic insights and best practices in...Read More
In Deutsche Zeitschrift für Klinische Forschung, German magazine for clinical trials, Kirill Timofeev, Principal Consultant at DataArt, explains how blockchain technologies will influence clinical trials in the near future.
In PM Report, a German professional pharmaceutical magazine, Anton Dolgikh, Head of AI in the Healthcare and Life Sciences Practice at DataArt, discusses the role of natural language processing in pharmacovigilance.